220 related articles for article (PubMed ID: 33144641)
1. Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.
Ibeji CU; Salleh NAM; Sum JS; Ch'ng ACW; Lim TS; Choong YS
Sci Rep; 2020 Nov; 10(1):18925. PubMed ID: 33144641
[TBL] [Abstract][Full Text] [Related]
2. Active Site Flexibility of Mycobacterium tuberculosis Isocitrate Lyase in Dimer Form.
Lee YV; Choi SB; Wahab HA; Choong YS
J Chem Inf Model; 2017 Sep; 57(9):2351-2357. PubMed ID: 28820943
[TBL] [Abstract][Full Text] [Related]
3. Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
Quartararo CE; Hadi T; Cahill SM; Blanchard JS
Biochemistry; 2013 Dec; 52(51):9286-93. PubMed ID: 24261638
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
[TBL] [Abstract][Full Text] [Related]
6. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics.
Zhou M; Xie L; Yang Z; Zhou J; Xie J
J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679
[TBL] [Abstract][Full Text] [Related]
7. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism.
Kwon S; Chun HL; Ha HJ; Lee SY; Park HH
PLoS One; 2021; 16(5):e0251067. PubMed ID: 33951112
[TBL] [Abstract][Full Text] [Related]
9. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
Lee YV; Wahab HA; Choong YS
Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
[TBL] [Abstract][Full Text] [Related]
10. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
11. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages].
Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266
[TBL] [Abstract][Full Text] [Related]
13. Probing the Catalytic Mechanism Involved in the Isocitrate Lyase Superfamily: Hybrid Quantum Mechanical/Molecular Mechanical Calculations on 2,3-Dimethylmalate Lyase.
Jongkon N; Chotpatiwetchkul W; Gleeson MP
J Phys Chem B; 2015 Sep; 119(35):11473-84. PubMed ID: 26224328
[TBL] [Abstract][Full Text] [Related]
14. ¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.
Beste DJ; Bonde B; Hawkins N; Ward JL; Beale MH; Noack S; Nöh K; Kruger NJ; Ratcliffe RG; McFadden J
PLoS Pathog; 2011 Jul; 7(7):e1002091. PubMed ID: 21814509
[TBL] [Abstract][Full Text] [Related]
15. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
[TBL] [Abstract][Full Text] [Related]
16. Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility.
Shukla H; Shukla R; Sonkar A; Pandey T; Tripathi T
Sci Rep; 2017 Apr; 7(1):1058. PubMed ID: 28432345
[TBL] [Abstract][Full Text] [Related]
17. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site.
Shukla R; Shukla H; Tripathi T
Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315
[TBL] [Abstract][Full Text] [Related]
18. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages.
Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N
Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909
[TBL] [Abstract][Full Text] [Related]
19. Targeting isocitrate lyase for the treatment of latent tuberculosis.
Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
[TBL] [Abstract][Full Text] [Related]
20. Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening.
Ji L; Long Q; Yang D; Xie J
Int J Biol Sci; 2011 Apr; 7(3):376-82. PubMed ID: 21494431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
